Using Early Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Patients With Chronic Myeloid Leukemia Who Are in Remission The imaging cohort consisted of positron emission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results